Efficacy of lateral lymph node dissection for local control of rectal cancer: A multicenter study

被引:0
|
作者
Tanaka, Yusuke [1 ]
Hino, Hitoshi [1 ,9 ]
Shiomi, Akio [1 ]
Uehara, Kay [2 ]
Watanabe, Jun [3 ]
Nishikawa, Takeshi [4 ]
Ueno, Hideki [5 ]
Kinugasa, Yusuke [6 ]
Kawai, Kazushige [7 ]
Ajioka, Yoichi [8 ]
机构
[1] Shizuoka Canc Ctr Hosp, Div Colon & Rectal Surg, Shizuoka, Japan
[2] Nippon Med Sch, Div Gastrointestinal & Hepatobiliary Pancreat Surg, Tokyo, Japan
[3] Yokohama City Univ, Gastroenterol Ctr, Med Ctr, Dept Surg, Yokohama, Japan
[4] Saitama Canc Ctr, Div Gastroenterol Surg, Ina, Japan
[5] Natl Def Med Coll, Dept Surg, Tokorozawa, Japan
[6] Tokyo Med & Dent Univ, Dept Gastrointestinal Surg, Tokyo, Japan
[7] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Colorectal Surg, Tokyo, Japan
[8] Niigata Univ, Grad Sch Med & Dent Sci, Div Mol & Diagnost Pathol, Niigata, Japan
[9] Shizuoka Canc Ctr Hosp, Div Colon & Rectal Surg, 1007 Shimonagakubo,Nagaizumi Cho, Shizuoka 4118777, Japan
来源
关键词
lateral lymph node dissection; lateral lymph node metastasis; local recurrence; rectal cancer; total mesorectal excision; PREOPERATIVE CHEMORADIOTHERAPY; MESORECTAL EXCISION; METASTASIS; BENEFIT; JAPAN;
D O I
10.1002/ags3.12789
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundThis study aimed to evaluate the efficacy of lateral lymph node dissection (LLND) for rectal cancer by comparing the local control in patients with and without pathological lateral lymph node metastasis (LLNM).MethodsWe included 189 patients with rectal cancer who underwent total mesorectal excision and LLND at 13 institutions between 2017 and 2019. Patients with and without pathological LLNM were defined as the pLLNM (+) and (-) groups, respectively. Propensity score-matching helped to balance the basic characteristics of both groups. The incidences of local recurrence (LR) and lateral lymph node recurrence (LLNR) were compared between the groups.ResultsIn the entire cohort, 39 of the 189 patients had pathological LLNM. The 3-year LR and LLNR rates were 18.3% and 4.0% (p = 0.01) and 7.7% and 3.3% (p = 0.22) in the pLLNM (+) and (-) groups, respectively. After propensity score matching, the data from 62 patients were analyzed. No significant differences in LR or LLNR were observed between both groups. The 3-year LR and LLNR rates were 16.4% and 9.8% (p = 0.46) and 9.7% and 9.8% (p = 0.99) in the pLLNM (+) and (-) groups, respectively.ConclusionLLND would lead to comparable local control in the pLLNM (+) and (-) groups if the clinicopathological characteristics except for LLNM are similar. This study compared the incidence of local recurrence (LR) and lateral lymph node recurrence (LLNR) after total mesorectal excision and lateral lymph node dissection (LLND) between patients with and without pathological lateral lymph node metastasis (LLNM), using multicenter prospective data to assess the impact of LLND on the local control of rectal cancer. In the entire cohort, the 3-year LR and LLNR rates were 18.3% and 4.0% (p = 0.01) and 7.7% and 3.3% (p = 0.22) in the patients with and without pathological LLNM, while no significant differences in LR or LLNR were observed between both groups after propensity score matching. LLND would lead to comparable local control in the patients with and without pathological LLNM if the clinicopathological characteristics except for LLNM are similar.image
引用
收藏
页码:631 / 638
页数:8
相关论文
共 50 条
  • [1] Neoadjuvant Chemoradiotherapy Prior to Lateral Lymph Node Dissection in Rectal Cancer with Suspected Lateral Lymph Node Metastasis: a Multicenter Lateral Node Study in China
    Zhou, Sicheng
    Song, Yan
    Xie, Yibin
    Liu, Qian
    JOURNAL OF GASTROINTESTINAL SURGERY, 2023, 27 (01) : 158 - 161
  • [2] Neoadjuvant Chemoradiotherapy Prior to Lateral Lymph Node Dissection in Rectal Cancer with Suspected Lateral Lymph Node Metastasis: a Multicenter Lateral Node Study in China
    Sicheng Zhou
    Yan Song
    Yibin Xie
    Qian Liu
    Journal of Gastrointestinal Surgery, 2023, 27 : 158 - 161
  • [3] Can neoadjuvant chemoradiotherapy before lateral pelvic lymph node dissection improve local control and prognosis in rectal cancer patients with clinically suspected lateral lymph node metastasis? A multicenter lateral node study in China
    Xie Z.
    Chen Q.
    Feng B.
    Jiang Y.
    Wang X.
    Xing W.
    Liu Q.
    BMC Cancer, 24 (1)
  • [4] LATERAL LYMPH NODE DISSECTION FOR ADVANCED RECTAL CANCER
    Akihiro, K.
    Saito, N.
    Sugito, M.
    Ito, M.
    Nishizawa, Y.
    ANNALS OF ONCOLOGY, 2009, 20 : 18 - 18
  • [5] Lateral Lymph Node Dissection for Lower Rectal Cancer
    Nakamura, T.
    Watanabe, M.
    WORLD JOURNAL OF SURGERY, 2013, 37 (08) : 1808 - 1813
  • [6] Lateral lymph node dissection for lower rectal cancer
    Shiozawa, Manabu
    Akaike, Makoto
    Yamada, Roppei
    Godai, Teni
    Yamamoto, Naoto
    Saito, Hiroshige
    Sugimasa, Yukio
    Takemiya, Shoji
    Rino, Yasushi
    Imada, Toshio
    HEPATO-GASTROENTEROLOGY, 2007, 54 (76) : 1066 - 1070
  • [7] Lateral Lymph Node Dissection for Lower Rectal Cancer
    T. Nakamura
    M. Watanabe
    World Journal of Surgery, 2013, 37 : 1808 - 1813
  • [8] Upfront surgery, neoadjuvant chemoradiotherapy, or neoadjuvant chemotherapy for rectal cancer with lateral lymph node metastasis: A multicenter MRI and lateral lymph node dissection study
    Miura, Takuya
    Kawai, Kazushige
    Fujita, Hiromasa
    Kazama, Shinsuke
    Ueno, Hideki
    Kinugasa, Yusuke
    Sakamoto, Kazuhiro
    Kobayashi, Hirotoshi
    Hakamada, Kenichi
    Ajioka, Yoichi
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2024,
  • [9] Lateral lymph node dissection for low rectal cancer: Is it necessary?
    Niki Christou
    Jeremy Meyer
    Christian Toso
    Frédéric Ris
    Nicolas Christian Buchs
    World Journal of Gastroenterology, 2019, (31) : 4294 - 4299
  • [10] Robotic surgery for rectal cancer with lateral lymph node dissection
    Watanabe, T.
    Hata, K.
    BRITISH JOURNAL OF SURGERY, 2016, 103 (13) : 1755 - 1757